To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?

por Freshwater, Dustin, Murphy, Nina, Hecker, Michelle T
Publicado 2017

2024. Modeled Impact of Rapid Diagnostics on the Treatment of Gram-Negative Bacteremia at a Tertiary-Care VA Medical Center

por Freshwater, Dustin, Stiefel, Usha, Perez, Federico, Akpoji, Ukwen, Hirsch, Amy, Burant, Christopher, Navas, Maria, Sims, Sharanie
Publicado 2018